Shoenfeld, Y., Carp, H.J., Molina, V., Blank, M., Cervera, R., Balasch, J., Tincani, A., Faden, D., Lojacono, A., Doria, A., Konova, E. and Meroni, P.L. (2006) Autoantibodies and Prediction of Reproductive Failure. American Journal of Reproductive Immunology, 56, 337-344.
http://dx.doi.org/10.1111/j.1600-0897.2006.00434.x

has been cited by the following article:

• TITLE: “Eli-P-Complex” Diagnostic Test for Preconception Care in Women with History of Adverse Pregnancy Outcome: A Randomized Multicenter Trial

  AUTHORS: Svetlana G. Tsakhilova, Tatiana E. Sharkovskaya, Olga A. Yakimovich, Aida M. Begizova, Angelina A. Malsagova

  KEYWORDS: APO-Adverse Pregnancy Outcomes, GC-Gestational Complications, RR-Relative Risk

  JOURNAL NAME: Advances in Reproductive Sciences, Vol.3 No.4, November 6, 2015

  ABSTRACT: Background: ELI-P-Complex is the most advanced diagnostic test designed to assess whether the female body is ready (or unready) for the normal pregnancy course and for giving birth to a healthy child. ELI-P-Complex enables the perceived abnormalities to be individually treated even prior to the pregnancy planning, thus minimizing the risk of gestational and delivery-related complications. This prospective study shows the effectiveness of ELI-P-Complex testing during preconception care in women with a history of adverse pregnancy outcomes (APO). Methods: The data were reviewed from 4519 women with a history of APO and who planned to get pregnant. Following randomization, subjects of Group A were tested with ELI-P-Complex and treated before the pregnancy based on the results obtained. Group B subjects were not examined using the ELI- P-Complex test and were prepared for pregnancy in accordance with the standard strategy of pre- conception care [1]. Results: In Group A, gestational complications (GC) were revealed in 20% of women compared to 88.7% of Group B subjects; the relative risk (RR) of GC was 11.67 (95% CI: 9.9851 to 13.6392; P